2026 Regular Session
HCR120
Creates the PACE Task Force to prioritize access, care, and education on GLP-1 medications
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Recorded floor votes
2 roll calls are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
May 31, 2026 · House
House Vote on HCR 120 FINAL CONSIDERATION (#1809)
Passed ⭐ Substantive final action
81 yea–11 nay · 13 absent
June 1, 2026 · Senate
Senate Vote on HCR 120 CONCUR (#1622)
Passed
33 yea–0 nay · 6 absent
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
House Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
-
Senate Signed by the President of the Senate.
-
House Enrolled and signed by the Speaker of the House.
-
House Received from the Senate without amendments.
-
Senate Received in the Senate; read by title. Rules suspended. Read second time by title and concurred in by a vote of 33 yeas and 0 nays. Ordered returned to the House. View roll call
-
House Read by title, roll called on final consideration, yeas 81, nays 11. The resolution was adopted and ordered to the Senate. View roll call
-
House Rules suspended, called out of its regular order.
-
House Scheduled for floor debate on 05/31/2026.
-
House Read by title, rules suspended, passed to 3rd reading.
-
House Read by title. Lies over under the rules.